Model Claims Drugged
Sort by
63 items
-
MarketWatch - Business
Bristol-Myers Squibb stock jumps on schizophrenia drug approval
Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.22 hours ago -
BBC News - Top stories
Starmer brands donor flat claims 'farcical'
The PM is facing questions around his use of Labour peer Lord Alli's flat for filming during the pandemic.Yesterday -
ABC News - Top stories
Newsmax reaches settlement with Smartmatic regarding 2020 election claims
Newsmax has reached a settlement with voting machine company Smartmatic, ending a lawsuit that accused the network of spreading false claims about the 2020 election.Yesterday -
ABC News - Top stories
Springfield officials declined to speak with Vance amid claims about Haitian migrants
Emails obtained by ABC News show Springfield, Ohio city officials declined to meet with former President Donald Trump’s running mate Sen. JD Vance earlier this month.Yesterday -
The Wall Street Journal - Business
Cassava Paying $40 Million to Settle Doctored Alzheimer's Drug Data Claims
The Securities and Exchange Commission alleged that a researcher for the company manipulated trial data to make its drug results look more promising.Yesterday -
ABC News - Top stories
FDA approves 1st new drug to treat schizophrenia in more than 30 years
The FDA on Thursday approved the first new drug to treat patients with schizophrenia in more than 30 years.Yesterday - FDA -
CNBC - Business
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.Yesterday - FDA -
MarketWatch - Business
Cassava Sciences settles SEC charges of ‘misleading’ Alzheimer’s trial claims
Shares of Cassava Sciences Inc. dropped more than 10% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged the pharma company and two ...Yesterday -
The New York Times - Health
F.D.A. Approves a New Antipsychotic Drug
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.Yesterday -
CBS Sports - Sports
Giants vs. Cowboys odds, prediction, time, spread: Thursday Night Football picks from NFL model on 42-22-run
SportsLine's model simulated Dallas Cowboys vs. New York Giants on Thursday Night Football 10,000 timesYesterday - NFL -
-
Inc. - Business
Weekly Jobless Claims Drop, Signaling Market Strength
Americans applying for unemployment benefits hit a four-month low, showing economic resilience.Yesterday -
The Wall Street Journal - Tech
Science Editors Raise New Doubts on Meta's Claims It Isn't Polarizing
The editorial warns that Facebook’s changes after the 2020 election may have swayed the conclusions of a prominent study.Yesterday -
The Wall Street Journal - Business
Newsmax and Smartmatic Settle Defamation Lawsuit Over False 2020 Election Claims
A trial in the case was set to begin Sept. 30, while Smartmatic has a separate suit pending against Fox News.Yesterday -
CNBC - Business
Trump ally Matt Gaetz says House Ethics panel issued subpoena for him in sex, drug probe
Florida Republican Rep. Matt Gaetz, a close Donald Trump ally, said he will no longer comply with an ethics investigation into sex and drug use allegations.Yesterday - Donald Trump -
The Guardian - World
Sexual assault claims made over Mohamed Al Fayed’s Fulham tenure
Lawyers for accusers say several allegations relate to Fayed’s time as football club’s owner. Sexual assault allegations have been made relating to Mohamed Al Fayed’s 16 years of ownership of ...Yesterday -
CBS Sports - Sports
2024 NFL futures: Ravens' outlook begins to improve, according to the SportsLine Projection Model
The reigning AFC North champions are on the rise in the model's updated projections after Week 3 of the NFL seasonYesterday - NFL